News Summary: Royalty Pharma raises Elan offer

Published



ANOTHER BID: Royalty Pharma said Friday it has raised its offer to buy Irish drugmaker Elan Corp. PLC. It is now offering $13 in cash for each Elan share, and it will give stockholders the right to receive up to an additional $2.50 per share in milestone-based payments.

ELAN’S RESPONSE: Elan said its board will review the new offer, and its shareholders should take no action in the meantime.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.